The chemistry problem doesn't stop at the active ingredient. Many compounders add extra ingredients, most commonly vitamin B12, to differentiate their product from FDA-approved versions — additives with no proven weight-loss benefit and largely untested combinations. A 2026 lab analysis published in Expert Opinion on Drug Safety found that combining tirzepatide with B12 can form an entirely new, previously uncharacterized molecule that doesn't exist in the approved drug; researchers say its effects on the body remain unknown. A separate academic review found nearly half of compounded products tested contained additives like cyanocobalamin, glycine, or niacinamide with little scientific justification. Layer in the FDA's documented dosing errors from multidose vials, where patients have measured out ten to twenty times the intended dose, and the picture becomes clear: without independent verification, there's no reliable way to know what you're actually getting. That's the exact gap third-party lab testing and batch-specific certificates of analysis are built to close — verifying identity, purity, and concentration before a product ever reaches a researcher's bench.
